论文信息 - [Marseille welcomes the FSHD Society International Research Conference].

[Marseille welcomes the FSHD Society International Research Conference].

Le colloque annuel de la FSHD Society s’invite à Marseille. Les 19 et 20 juin 2019, la conférence internationale sur la recherche dans la dystrophie facio-scapulo-humérale (FSHD) a eu lieu à Marseille. La rencontre rassemblant 180 participants, médecins, scientifiques et patients était organisée au Palais du Pharo à Marseille. Ce site historique emblématique surplombant le Vieux Port et faisant face à Notre Dame de la Garde a été construit dans la seconde moitié du XIXe siècle par Napoléon III pour son épouse, l’impératrice Eugénie.

[1] W. Wright,et al. Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy , 2019, Experimental Neurology.

[2] Jay J. Han,et al. Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy , 2019, Neuromuscular Disorders.

[3] M. Lamers,et al. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain , 2019, Journal of Medical Genetics.

[4] S. Tapscott,et al. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[5] G. Siciliano,et al. Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy , 2019, Muscle & nerve.

[6] S. Tapscott,et al. MRI‐informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD , 2018, Human molecular genetics.

[7] F. Magdinier,et al. Analysis of the 4q35 chromatin organization reveals distinct long-range interactions in patients affected with Facio-Scapulo-Humeral Dystrophy , 2018, bioRxiv.

[8] B. Engelen,et al. 225th ENMC international workshop: A global FSHD registry framework, 18–20 November 2016, Heemskerk, The Netherlands , 2017, Neuromuscular Disorders.